New Delhi: To provide relief to cancer patients, the government has intensified its monitoring of the prices of 137 cancer drugs. The National Pharmaceutical Pricing Authority (NPPA) has directed state drug controllers to ensure that pharmaceutical companies, medical stores, and hospitals adhere to the newly prescribed prices.
The new prices for these drugs came into effect on November 9. Pharmaceutical companies, retailers, and hospitals are now required to sell these medicines strictly at the fixed prices. Furthermore, they must display the list of these new prices at their retail outlets and on their websites.
The Authority has made it clear that any retailer or company found charging more than the fixed price will face punitive action. The objective is to ensure that cancer patients can access these medicines at fair and affordable prices.
Patients can lodge complaints regarding overcharging, shortages, or the unavailability of these medicines through the ‘Pharma Sahi Daam’ (Fair Price for Medicines) app or portal. Additionally, complaints can be registered via the helpline number 1800-111-255 or through the official website. The Authority has instructed state drug controllers to submit a report on the actions taken by November 16, 2026.
